
Gene Replacement Therapy in SMA: ICNMD Lunch Symposium
Date and time
Description
Gene replacement therapy is being tested as a potential treatment for spinal muscular atrophy. What does this mean for other neuromuscular diseases? Find out when experts Eugenio Mercuri, Richard Finkel, and Gyula Acsadi discuss how gene therapy works in SMA and compare other gene modifying therapies that are available. Lunch will be provided for this lively discussion that you don't want to miss!
This presentation was approved by the Scientific Program Committee as an independent activity held in conjunction with the 15th International Congress on Neuromuscular Diseases. This presentation is not sponsored or endorsed by ICNMD 2018.